PERSIST AI SUITE/ 01
AI deployed on your cloud.
A self improving AI model that is proprietary to you. Continuously build your knowledge base and 10x your formulation staff's expertise.
Learn more about Persist AI Suite10× Faster Formulation
Discovery
Get to a target product profile faster using AI + Robotics
Formulation is often limited by slow, manual iteration.
We accelerate it with AI-guided design and robotic execution.
PRODUCTS & SERVICES
Formulation support, on your terms.
CLOUD LAB/ 02
You design. We execute.
Design experiments with full control. We execute them in our robotic lab, and results stream directly to your dashboard—all online.
Learn more about Cloud LabRELEASE PLATFORM · CAM 02
EXECUTING
θ₁ 84.0°EXT 112.0mm
T+ 00:00:00
FULL SERVICE/ 03
We design, execute, and optimize.
From molecule to in vivo-ready formulation, send your molecule, and we'll design, execute, and optimize your strategy using AI, robotics, and deep formulation expertise.
Learn more about formulation development
Persist's high throughput formulation screening and AI-driven predictions are revolutionary.
Firouz Asgarzadeh, PhD
OSD Pharmaceuticals Solutions Inc.
CASE STUDIES
Real results from real projects.
| Area | Customer challenge | Persist result | Timeline |
|---|---|---|---|
| Nanoparticle | Unstable formulation, variable drug loading batch to batch | 60%drug loading achieved | 28 days vs. 3–6 months industry standard |
| Extended release | Hydrophilic API released within a day despite 6 months of optimization | 1 wk+sustained release | 2 weeks vs. 6 months spent by customer |
| Peptide | Scarce, expensive hydrophilic peptide with a short half life | 14 dayhalf life extension | 3 months vs. 3 years spent by customer |
| SEDDS | Needed 20% drug load in a lipid formulation for a high molecular weight drug | 7formulations to reach QTPP | < 2 weeks vs. considered impossible by customer |
| Stability | Refrigerated product needed reformulation for room-temperature shelf-life stability | 4RT-stable formulation candidates | < 1 month vs. 1 year industry standard |
PARTNERS & INVESTORS
Working with leaders across biotech and beyond.
RECENT NEWS
Stay up to date.
Feb 16, 20263 min read
Why Our Partnership with CyanoCapture Excites Me
Persist AI is partnering with CyanoCapture to build the world's first GMP manufacturing platform for delivering peptides and proteins orally through cyanobacteria.
Read articleJun 14, 20254 min read
Persist AI Welcomes Dr. Amjad Basha Mohammad and Dr. Ramesh Rachapudi to Expand Computational Modeling and Product Development Capabilities
We're excited to continue advancing as an AI-driven pharmaceutical development pioneer by strengthening our computational modeling and product development capabilities.
Read articleMay 19, 20254 min read
Beyond the $12M: Revolutionizing Drug Formulation Development at Persist AI
We're fundamentally changing how quickly drugs go from molecule to product for patient use. At Persist AI, we're excited to announce our $12M Series A.
Read articleGET IN TOUCH
Let's Discuss Your Formulation Needs
Tell us about the molecule, the constraint, or the target profile — we'll reply within one business day.